---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-004253"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2026-06-23T20:05:18+00:00"
generated_at: "2026-06-23T20:08:00.202906+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Anika shareholders approve share reserve increases for equity plans at annual meeting

## Summary
- Stockholders approved amendment to 2017 Omnibus Incentive Plan, increasing reserved shares from 5,760,000 to 6,110,000 (350,000 share increase).
- Stockholders approved amendment to 2021 Employee Stock Purchase Plan, increasing reserved shares from 200,000 to 400,000 (200,000 share increase).
- Directors Gary P. Fischetti, John B. Henneman III, and Stephen D. Griffin elected as Class III directors until 2029 annual meeting.
- Ratification of Deloitte & Touche as independent auditor for FY2026 passed: 11,136,590 for, 24,966 against, 34,111 abstain.
- Advisory say-on-pay vote passed: 8,268,676 for, 1,093,946 against, 31,179 abstain; 1,801,866 broker non-votes.

## SEC filing metadata
- accession: 0001171843-26-004253
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2026-06-23T20:05:18+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/0001171843-26-004253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/f8k_062326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-004253
- JSON: https://secwatch.observer/filing/0001171843-26-004253.json
- Plain text: https://secwatch.observer/filing/0001171843-26-004253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.